Cargando…

‘Real-life’ reduction in cholesterol with statins, 1993 to 2002

AIMS: To evaluate the impact of lipid-lowering treatment on cholesterol concentrations in the setting of normal care. METHODS: This was a retrospective review of all cholesterol measurements made in Tayside, Scotland, between 1993 and 2002, linked to dispensed prescribing data for lipid-lowering dru...

Descripción completa

Detalles Bibliográficos
Autores principales:	Murphy, Michael J, Wei, Li, Watson, Alexander D, MacDonald, Thomas M
Formato:	Texto
Lenguaje:	English
Publicado:	Blackwell Science Inc 2008
Materias:	Pharmacoepidemiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2291374/ https://www.ncbi.nlm.nih.gov/pubmed/18241286 http://dx.doi.org/10.1111/j.1365-2125.2007.03066.x

Ejemplares similares

Impact of allopurinol use on urate concentration and cardiovascular outcome
por: Wei, Li, et al.
Publicado: (2011)

Spironolactone use and risk of incident cancers: a retrospective, matched cohort study
por: Mackenzie, Isla S., et al.
Publicado: (2016)

A historical cohort study to investigation of statins safety in COVID-19 hospitalized patients
por: Nateghi, Saeed, et al.
Publicado: (2022)

Influenza H1N1 (swine flu) vaccination: a safety surveillance feasibility study using self-reporting of serious adverse events and pregnancy outcomes
por: Mackenzie, Isla S, et al.
Publicado: (2012)

Contribution of real-life studies in France during the COVID-19 pandemic and for the national pharmaco-epidemiological surveillance of COVID-19 vaccines
por: Zureik, Mahmoud, et al.
Publicado: (2023)

A population-based study of the drug interaction between clopidogrel and angiotensin converting enzyme inhibitors
por: Cressman, Alex M, et al.
Publicado: (2015)

Statin discontinuation in persons with and without Alzheimer’s disease
por: Vu, Mai, et al.
Publicado: (2022)

Prevalence and initiation of statin therapy in the oldest old—a longitudinal population-based study
por: Sundvall, Helena, et al.
Publicado: (2022)

The potential of training specialist oncology nurses in real-life reporting of adverse drug reactions
por: Reumerman, M., et al.
Publicado: (2021)

Validation of the Swedish Multiple Sclerosis Register: Further Improving a Resource for Pharmacoepidemiologic Evaluations
por: Alping, Peter, et al.
Publicado: (2019)

Validation of suicide and self-harm records in the Clinical Practice Research Datalink
por: Thomas, Kyla H, et al.
Publicado: (2013)

Trends in the use of oral anticoagulants, antiplatelets and statins in four European countries: a population-based study
por: García Rodríguez, Luis A., et al.
Publicado: (2021)

A multinational, drug utilization study to investigate the use of dexmedetomidine (Dexdor®) in clinical practice in the EU
por: Weatherall, Mary, et al.
Publicado: (2017)

Prevalence and characteristics of adverse drug reactions at admission to hospital: a prospective observational study
por: Chan, Sze Ling, et al.
Publicado: (2016)

Decrease in loop diuretic treatment from 2005 to 2014 in Swedish real-life patients with chronic heart failure
por: Parén, Pär, et al.
Publicado: (2018)

Prevalence, nature and potential preventability of adverse drug events – a population-based medical record study of 4970 adults
por: Hakkarainen, Katja M, et al.
Publicado: (2014)

The effectiveness of pharmaceutical interventions for obesity: weight loss with orlistat and sibutramine in a United Kingdom population-based cohort
por: Douglas, Ian J, et al.
Publicado: (2015)

A population database study of outcomes associated with vitamin K antagonists in atrial fibrillation before DOAC
por: Blin, Patrick, et al.
Publicado: (2015)

Angiotensin receptor blockers and risk of dementia: cohort study in UK Clinical Practice Research Datalink
por: Goh, Kah L, et al.
Publicado: (2015)

Risk of acute and serious liver injury associated to nimesulide and other NSAIDs: data from drug‐induced liver injury case–control study in Italy
por: Donati, Monia, et al.
Publicado: (2016)

Evaluation of the risk of cardiovascular events with clarithromycin using both propensity score and self‐controlled study designs
por: Root, Adrian A., et al.
Publicado: (2016)

EUROmediCAT signal detection: an evaluation of selected congenital anomaly‐medication associations
por: Given, Joanne E., et al.
Publicado: (2016)

Adverse drug reaction reporting and development of pharmacovigilance systems in Bosnia and Herzegovina, Croatia, Serbia, and Montenegro: a retrospective pharmacoepidemiological study
por: Glamočlija, Una, et al.
Publicado: (2018)

Patterns of antiplatelet drug use after a first myocardial infarction during a 10‐year period
por: Yasmina, Alfi, et al.
Publicado: (2016)

Evaluation of Medication-mediated Effects in Pharmacoepidemiology
por: Tchetgen Tchetgen, Eric J., et al.
Publicado: (2017)

Evaluating beneficial drug effects in a non‐interventional setting: a review of effectiveness studies based on Swedish Prescribed Drug Register data
por: Wallerstedt, Susanna M., et al.
Publicado: (2017)

Targeted Maximum Likelihood Estimation for Pharmacoepidemiologic Research
por: Pang, Menglan, et al.
Publicado: (2016)

Comparison of Antihypertensive Drug Classes for Dementia Prevention
por: Walker, Venexia M., et al.
Publicado: (2020)

Prenatal Opioid Analgesics and the Risk of Adverse Birth Outcomes
por: Brogly, Susan B., et al.
Publicado: (2021)

Causal Effect of Chronic Pain on Mortality Through Opioid Prescriptions: Application of the Front-Door Formula
por: Inoue, Kosuke, et al.
Publicado: (2022)

Impact of coronavirus disease 2019 on contraception use in France
por: Roland, Noémie, et al.
Publicado: (2023)

Medication adherence among persons with coronary heart disease and associations with blood pressure and low-density-lipoprotein-cholesterol
por: Pedersen, Elisabeth, et al.
Publicado: (2022)

Contribution of prolonged-release melatonin and anti-benzodiazepine campaigns to the reduction of benzodiazepine and z-drugs consumption in nine European countries
por: Clay, Emilie, et al.
Publicado: (2012)

The use of opioids at the end of life: knowledge level of pharmacists and cooperation with physicians
por: Borgsteede, Sander D., et al.
Publicado: (2010)

Pattern of treatment of behavioural and psychological symptoms of dementia and pain: evidence on pharmacoutilization from a large real-world sample and from a centre for cognitive disturbances and dementia
por: Scuteri, Damiana, et al.
Publicado: (2020)

Adequate, questionable, and inadequate drug prescribing for older adults at the end of life: a European expert consensus
por: Morin, Lucas, et al.
Publicado: (2018)

Antidepressants and suicidal behaviour in late life: a prospective population-based study of use patterns in new users aged 75 and above
por: Hedna, Khedidja, et al.
Publicado: (2017)

Appropriateness of treatment recommendations for PPI in hospital discharge letters
por: Ahrens, Dirk, et al.
Publicado: (2010)

Who gets prescriptions for proton pump inhibitors and why? A drug-utilization study with claims data in Bavaria, Germany, 2010–2018
por: Rückert-Eheberg, Ina-Maria, et al.
Publicado: (2021)

Systemic quinolones and risk of retinal detachment III: a nested case–control study using a US electronic health records database
por: Taher, Mohamed Kadry, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vugm9f1voc2eu1ib6glps3h3j0